Migration signals serve a fundamental function in the development of thymocytes. As thymocytes travel to distinct sites in the thymus, they undergo selection, differentiation and proliferation until they are mature and are exported 1 . The transition between sites in the thymus and stages of development depends on interactions with resident cells found in distinct compartments 1 . For example, CD4 + CD8 + doublepositive (DP) thymocytes interact with thymic epithelial cells in the cortex (cTECs) and undergo positive selection by using their newly assembled T cell antigen receptors (TCRs) to recognize complexes of self peptide-major histocompatibility complex (pMHC) expressed by the cTECs. Most DP thymocytes die because they fail to receive appropriate signals from TCR-pMHC interactions. A small number of DP thymocytes successfully undergo positive selection and differentiate into CD4 + or CD8 + single-positive thymocytes.
Migration signals serve a fundamental function in the development of thymocytes. As thymocytes travel to distinct sites in the thymus, they undergo selection, differentiation and proliferation until they are mature and are exported 1 . The transition between sites in the thymus and stages of development depends on interactions with resident cells found in distinct compartments 1 . For example, CD4 + CD8 + doublepositive (DP) thymocytes interact with thymic epithelial cells in the cortex (cTECs) and undergo positive selection by using their newly assembled T cell antigen receptors (TCRs) to recognize complexes of self peptide-major histocompatibility complex (pMHC) expressed by the cTECs. Most DP thymocytes die because they fail to receive appropriate signals from TCR-pMHC interactions. A small number of DP thymocytes successfully undergo positive selection and differentiate into CD4 + or CD8 + single-positive thymocytes.
The motile nature of thymocytes facilitates their search for potentially rare TCR-reactive pMHC molecules on cTECs. Multiple interactions with distinct cTECs may occur, and DP thymocytes must integrate the individual signaling events with cTECs to initiate fate decisions. Thus, maintaining a fine balance between motility and duration of interactions with cTECs may be critical for successful positive selection. Advances in two-photon laser-scanning microscopic imaging have shed light on the motility and interactivity of DP thymocytes during positive selection in the cortex [1] [2] [3] [4] [5] . One study has shown that the vast majority of DP thymocytes move randomly at relatively low motility rates of 3-8 μm/min (ref. 3) . In another study, TCR-transgenic DP thymocytes on a positively selecting background showed a greater duration of interactions with cTECs than that of DP thymocytes on a nonselecting background 4 . Such observations allow the prediction that if thymocyte-stromal cell interactions are altered, for example, by changes in chemokine-mediated motility signals, the efficiency of positive selection might be compromised.
Chemokines such as CCL25 (TECK (A002265)) and CXCL12 (SDF-1 (A002142)) are expressed throughout the thymic cortex [6] [7] [8] , and their receptors, CCR9 (A000632) and CXCR4 (A000636), respectively, have high expression in DP thymocytes 9 . However, the migratory response of thymocytes is not dictated simply by the amount of chemokine receptor expression. For example, preselection DP thymocytes do not migrate efficiently to CCL25 despite the fact that CCR9 expression is similar on nonselected CD69 lo DP cells and positively selected CD69 hi DP cells 10, 11 . Positively selecting signals from the TCR-pMHC interaction may therefore render thymocytes more responsive to CCL25 (ref. 10) .
The GIT family of proteins, composed of GIT1 and GIT2 (A001041), are multifunctional proteins characterized by an N-terminal GTPaseactivating protein domain for the ADP-ribosylation factor (Arf) family of small GTP-binding proteins [12] [13] [14] [15] [16] . In peripheral T cells and thymocytes, GIT2 is the predominantly expressed isoform. GIT1 and GIT2 show GTPase-activating activity toward Arf1 and Arf6 (refs. 17,18) , which influences membrane traffic and actin remodeling 14 . Notably, Arf6 has been specifically linked to the formation of actinrich protrusions and membrane ruffles by activation of the small GTPase Rac [19] [20] [21] . GIT proteins interact with many molecules, such as G protein-coupled receptor kinases 22 , PIX (p21-activated kinase (PAK)-interacting exchange factor) 23 and paxillin 24 , and serve a pivotal role in focal adhesion disassembly 15 , cell polarity and the 5 0 4 VOLUME 11 NUMBER 6 JUNE 2010 nature immunology A r t i c l e s directional motility of migrating adherent cells 25 , neuronal cells 26 and neutrophils 13, 27 . Part of the function of GIT proteins may stem from their ability to repress Rac activation. For example, GIT2 represses Rac-dependent lamellipodia extension and cell spreading in HeLa human cervical cancer cells 25 and in migrating adherent cells 28 .
Although GIT2 is crucial in the regulation of the migration, adhesion and polarity of nonhematopoietic cells, understanding of the role of GIT2 in T cells is very limited. GIT interacts with PIX and PAK constitutively in a trimolecular complex in T cells 29 , and the GIT-PIX-PAK complex is recruited to the T cell immunological synapse by PIX 30 , but it is not clear what specific role GIT2 has in T cell function or development. Because rapid cytoskeletal rearrangement is fundamental for motility, it is possible that the GIT2 has a role in governing T cell motility.
Here we report that the generation of mature CD4 + single-positive (CD4SP) thymocytes in TCR-transgenic Git2 −/− mice was impaired due to inefficient positive selection. However, the TCR signaling ability as well as cell death and apoptosis of Git2 −/− thymocytes were unimpaired. Instead, we found that migration in response to SDF-1 and CCL25 in vitro by Git2 −/− DP thymocytes was enhanced. Furthermore, in response to SDF-1, Git2 −/− thymocytes showed greater motility in a collagen matrix and exaggerated Rac activation and actin polymerization. More Git2 −/− DP thymocytes than wild-type DP thymocytes migrated to SDF-1 in the presence of a TCR-mediated stop signal. To determine how the inappropriate chemokine response of Git2 −/− thymocytes affected thymocyte motility in vivo, we used two-photon laser-scanning microscopy to monitor migratory activity in intact thymic lobes. Paradoxically, we observed lower motility of Git2 −/− thymocytes, accompanied by accumulation of Git2 −/− thymocytes in certain areas of the cortex, including an area adjacent to SDF-1 + small blood vessels. We propose that the in vivo migratory defect of the Git2 −/− thymocytes is a steady-state consequence of thymocytes that were trapped by an exaggerated response to local chemokine gradients in the cortex, thus compromising their ability to receive proper TCR signals for efficient positive selection.
RESULTS

Generation of GIT2-deficient mice
We generated Git2 −/− mice using an available embryonic stem cell line with a gene-trapped Git2 gene. We confirmed insertion site of the retroviral vector by genomic sequencing of embryonic stem cells ( Supplementary  Fig. 1a) . Git2 −/− mice were born healthy at normal Mendelian ratios. Targeted mice had more than 90% less GIT2 mRNA than did wild-type mice (Supplementary Fig. 1b) . The remaining 10% expression of mRNA was probably due to alternative splicing. Likewise, protein expression was more than 90% lower in the thymus of homozygous Git2 −/− mice (Supplementary Fig. 1c) . GIT proteins exist in two forms, GIT1 and GIT2. GIT1 has higher expression in the brain and much lower expression in the thymus and spleen than does GIT2 (Supplementary Fig. 1c,d) , which establishes GIT2 as the main isoform expressed in T cells 31 . Thus, we focused on determining the role of GIT2 in T cells. We backcrossed the Git2 −/− line for nine generations to the C57BL/6 and BALB/c backgrounds. Git2 −/− mice on either background did not manifest any substantial change in T cell and B cell populations in the thymus, spleen and lymph nodes except that the number and percentage of marginal zone B cells was higher ( Supplementary Fig. 2a,b) .
Fewer CD4SP cells in TCR-transgenic Git2 −/− mice Developmental defects associated with thymocyte selection can be masked by compensatory changes in the TCR repertoire. Thus, we introduced single αβTCR transgenes into wild-type and Git2 −/− mice to limit compensation. We used two independent MHC class IIrestricted TCR-transgenic models: ovalbumin peptide-specific DO11.10 and OT-II. The number and percentage of CD4SP cells was much lower in both DO11.10 TCR-transgenic Git2 −/− thymus (Fig. 1a,b) and OT-II TCR-transgenic Git2 −/− thymus than in TCRtransgenic wild-type thymus ( Supplementary Fig. 3a,b) . The population with the greatest decrease in DO11.10 + Git2 −/− thymus was the mature TCR transgene-high population (recognized by the clonotypic Fig. 1c and Supplementary Fig. 3c , OT-II). Small numbers of DP thymocytes that have undergone positive selection upregulate CD69, CD3 and the TCR transgene. The KJ1-26 hi CD69 hi population of DP thymocytes was consistently smaller in DO11.10 + Git2 −/− mice (Fig. 1d) . Consistent with that lower number of CD4SP thymocytes, the percentage and number of transgene-positive peripheral CD4 + T cells in the spleen, lymph node and blood were much lower in TCR-transgenic Git2 −/− mice (Fig. 1e,f, Supplementary Fig. 3d and data not shown).
Impaired positive selection in TCR-transgenic Git2 −/− mice To assess the efficiency of generating CD4SP from DP thymocytes, we exposed mice to continuous bromodeoxyuridine (BrdU) and measured its incorporation (Fig. 2a) . The percentage of BrdU + DP thymocytes was similar in TCR-transgenic wild-type and Git2 −/− thymocytes. However, the percentage of BrdU + TCR-transgenic CD4SP thymocytes was much lower, which suggested that the generation of TCR-transgenic CD4SP thymocytes was impaired in TCR-transgenic Git2 −/− mice.
To determine whether the smaller number of CD4SP thymocytes was due to more death or apoptosis of TCR-transgenic Git2 −/− cells, we stained thymocytes with annexin V and 7-amino-actinomycin D after 4 h and 24 h of incubation in medium containing 10% fetal bovine serum (Fig. 2b) or with anti-CD3 and anti-CD28 (data not shown). We did not detect any substantial difference in cell death or apoptosis. Moreover, the percentage of active caspase-3-positive cells was similar in all subsets of TCR-transgenic wild-type and Git2 −/− thymocytes (Fig. 2c) .
To determine whether the absence of GIT2 affected negative selection, we introduced the H-Y TCR transgene into Git2 −/− mice. H-Y TCR-transgenic mice express a TCR specific for the male H-Y antigen presented by the H-2D b MHC class I molecule. Thymocytes bearing the transgenic TCR are positively selected in female mice but are deleted by negative selection in male mice 32, 33 . We did not detect any difference in negative selection in H-Y Git2 −/− thymocytes from male mice ( Supplementary Fig. 3e,f) . In contrast, the generation of CD8 + single-positive (CD8SP) thymocytes in female H-Y TCR-transgenic Git2 −/− mice was impaired (data not shown), which suggested that positive selection on MHC class I is also disrupted in the absence of GIT2. To further examine whether greater negative selection occurs at the CD4SP or CD8SP stage in the thymus or in the periphery, we measured expression of the β-chain variable region (V β ) in wild-type or Git2 −/− mice on the BALB/c background. Deletion of certain cells expressing the V β TCR occurs in this background because of endogenous expression of superantigen. However, we found no evidence of altered deletion of cell expressing V β 3, V β 5 or V β 11 in Git2 −/− mice in the thymus, spleen or lymph nodes ( Fig. 2d and data not shown). We conclude that greater cell death or negative selection does not account for the smaller number of CD4SP Git2 −/− thymocytes expressing the TCR transgene. Thus, GIT2 function is required for efficient positive selection under conditions in which TCR affinity is fixed.
Hematopoietic cell-intrinsic defect in Git2 −/− positive selection To determine whether the defect in positive selection was intrinsic to hematopoietic cells, we generated chimeras reconstituted with DO11.10 + wild-type bone marrow or DO11.10 + Git2 −/− bone marrow (Fig. 3a) . The generation of CD4SP thymocytes from DO11.10 + Git2 −/− bone marrow was substantially less than their generation from wild-type chimera. In addition, we determined whether nonhematopoietic cells from Git2 −/− thymus contributed to impaired positive selection. We generated chimeras by using wild-type or Git2 −/− mice as hosts and DO11.10 + wild-type mice as bone marrow donors, but did not detect any difference between wild-type and Git2 −/− hosts ( Fig. 3b) , which suggested that nonhematopoietic cells from Git2 −/− mice are able to provide a thymic environment that fosters proper thymocyte development. Because CD4SP thymocytes were considerably less abundant in DO11.10 + Git2 −/− chimera, their thymic medulla was substantially smaller than the thymus of DO11.10 + wild-type chimera (Fig. 3c) . Next, we assessed competitive repopulation of the thymus. Using OT-II + wild-type (CD45.1 + CD45.2 + ) and OT-II + Git2 −/− (CD45.2 + ) donor bone marrow cells mixed at a ratio of 1:1, we generated mixed-bone marrow chimeras. After 2 months, injection of equal amounts of bone marrow stem cells resulted in roughly equal representation at the double-negative stage (55% OT-II + wild-type and 45% OT-II + Git2 −/− ; Fig. 3d ), which suggested that 
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wild-type and Git2 −/− thymic progenitors entered the thymus and generated double-negative thymocytes similarly. At the DP stage in OT-II + wild-type and OT-II + Git2 −/− mixed-bone marrow chimeras, the representation of OT-II + wild-type and OT-II + Git2 −/− thymocytes was slightly shifted in favor of OT-II + wild-type population (60% OT-II + wild-type and 40% OT-II + Git2 −/− ). However, comparison of the OT-II + Git2 −/− population at the double-negative stage with the OT-II + Git2 −/− population at the DP stage showed that reconstitution from OT-II + Git2 −/− donor cells was not significantly different between the two stages (P = 0.56). In contrast, at the CD4SP stage and subsequent mature peripheral populations in the spleen, lymph nodes and blood, OT-II + Git2 −/− cells were substantially underrepresented compared with OT-II + wild-type cells, which suggests that OT-II + Git2 −/− thymocytes have an intrinsic developmental disadvantage at the transition from the DP stage to the CD4SP stage. Together these data show that defective generation of CD4SP thymocytes and CD4 + T cells in the periphery in TCR-transgenic Git2 −/− mice is intrinsic to hematopoietic cells.
Similar Erk activation and Ca 2+ increase in Git2 −/− thymocytes Defects in positive selection are often due to impaired TCR-induced signaling events at the DP stage. As the kinase Erk has a key role in positive selection, we assessed Erk activation in DP or CD4SP populations. We did not detect any substantial defects in Erk activation in DP thymocytes (Supplementary Fig. 4a ) or CD4SP thymocytes (data not shown). Global tyrosine phosphorylation and activation of the mitogen-activated protein kinase p38 after TCR stimulation were similar in wild-type and Git2 −/− thymocytes (data not shown). We also failed to detect alterations in the increase in intracellular calcium after TCR stimulation in the Git2 −/− DP or CD4SP subset ( Supplementary  Fig. 4b ). CD5 expression at the DP stage is proportional to TCR signaling strength 34 and was only slightly lower in DO11.10 + Git2 −/− DP thymocytes ( Supplementary Fig. 4c,d ). GIT2 interacts with PIX and PAK (via PIX). To determine whether the association of PIX and PAK is affected by GIT2 deficiency, we immunoprecipitated PAK2 from resting or TCR-stimulated wild-type and Git2 −/− thymocytes, followed by immunoblot analysis with an antibody that recognizes α-and β-isoforms of PIX and an antibody that recognizes both GIT1 and GIT2 ( Supplementary Fig. 5a and data not shown). We found that PAK2 interacted with the α-and β-isoforms of PIX similarly in the presence or absence of GIT2 and that the in vitro kinase activity of PAK2 was not changed in the absence of GIT2 after TCR stimulation ( Supplementary  Fig. 5b ). Rac activation was also similar in wild-type and Git2 −/− thymocytes after TCR stimulation (Supplementary Fig. 5c ).
GIT2 negatively regulates T cell motility
As GIT2 has been linked to cellular processes that govern cell migration in nonhematopoietic cells, we determined whether the GIT2 deficiency affected thymocyte motility. We found that the migration of Git2 −/− thymocytes was much greater in response to SDF-1 and CCL25, with the DP subset thymocytes showing the most substantial change (Fig. 4a) . In the absence of any stimulus, basal migration was modestly but consistently greater for the CD4SP and CD8SP subsets of Git2 −/− thymocytes. CD4SP and CD8SP thymocytes have abundant expression of CCR7, the receptor for the chemokines CCL19 (ELC) and CCL21 (SLC), and migrate efficiently toward these chemokines. The migration responses of wild-type and Git2 −/− thymocytes to CCL19 and CCL21 were similar (Supplementary Fig. 6a ), which suggested the enhanced migration of Git2 −/− thymocytes was specific to CCL25 and SDF-1. Expression of receptors for the chemokines SDF-1, CCL25 and CCL19 (CCL21)-CXCR4, CCR9 and CCR7, respectively-was similar in wild-type and Git2 −/− DP and CD4SP thymocytes (Supplementary Fig. 6b ). Although all DP thymocytes express a similar amount of the receptor for CCL25, CD69 hi DP thymocytes show enhanced migration toward CCL25 (refs. 10,11,35) . Because Git2 −/− DP thymocytes showed greater migration toward CCL25 and SDF-1, we determined which population of DP thymocytes was responsible for the higher response. The small CD69 hi TCRβ hi subset of DP thymocytes has been positively selected (post-selection DP thymocytes), whereas most DP thymocytes are CD69 lo TCRβ lo and have not undergone the positive selection process (preselection DP thymocytes). Post-selection DP thymocytes that migrated in response to CCL25 represented almost half of the total migrated DP thymocytes, despite the fact that this population represented a relatively small proportion of input cells (Fig. 4b) . In contrast, most of the migrated Git2 −/− DP thymocytes were preselection DP thymocytes (Fig. 4b) . Wild-type preselection DP thymocytes did not migrate as efficiently, which resulted in the migration of only 10% of the input cells in response to CCL25 (Fig. 4c) . We found that 26% of input Git2 −/− preselection DP thymocytes migrated in response to CCL25, which resulted in 2.6-fold more than the same population of wild-type DP thymocytes (Fig. 4c) . Git2 −/− post-selection DP thymocytes also showed greater migration to CCL25, although it was less prominent than that of the preselection population. We observed similar differences in the migratory activity in Git2 −/− preselection DP thymocytes in response to SDF-1 (Fig. 4c) . These results demonstrate that GIT2 suppresses the migration of DP thymocytes to CCL25 or SDF-1, especially at the preselection stage.
Greater motility of Git2 −/− thymocytes Chemokines enhance directional migration (chemotaxis) as well as random migration (chemokinesis). To distinguish chemokinesis from chemotaxis, we examined thymocyte migration from the upper well of a Transwell apparatus under conditions in which SDF-1 was added to the bottom well only, to the upper well only, or to both the top and bottom wells. If the enhanced migration of Git2 −/− thymocytes to SDF-1 were simply due to greater chemokinesis, migration under conditions in which SDF-1 was added to the upper well or both wells would be similar to migration when SDF-1 was added to the bottom well. When we added SDF-1 to the top well or to both wells, Git2 −/− thymocytes showed more migration than did wild-type cells (Fig. 5a) , which suggested that the chemokinesis of Git2 −/− thymocytes was indeed enhanced. However, Git2 −/− thymocytes migrated best when we added SDF-1 only to the bottom well, which suggested that the directional migration of Git2 −/− thymocytes was indeed enhanced. To further examine whether GIT2 deficiency resuts in greater directional motility, we measured the directional migration of wildtype and Git2 −/− thymocytes on a two-dimensional surface coated with the adhesion molecule ICAM-1 using SDF-1-releasing alginate beads and time-lapse fluorescence microscopy. Alginate beads can be used to adsorb SDF-1 and then release SDF-1 in a controlled manner 36 . We labeled wild-type and Git2 −/− thymocytes with the vital dyes CFSE and CMTMR, respectively, and applied them to the ICAM-1-coated surface in the presence of control beads or beads loaded with SDF-1. We found that both wild-type and Git2 −/− thymocytes sensed the SDF-1-releasing beads and migrated toward them ( Supplementary Fig. 7 and Supplementary Movie 1), which suggested that directional sensing to SDF-1 is intact in the absence of GIT2. We also measured directional migration on a two-dimensional ICAM-1-coated surface overlaid with collagen matrix to prevent convection in the presence of unloaded or SDF-1-loaded beads (Fig. 5b) . When we added unloaded beads, the average migration speed of wild-type and Git2 −/− thymocytes was 2.4 μm/min and 2.5 μm/min, respectively. In the presence of SDF-1-releasing beads, the average migration speed was higher for both wild-type 
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and Git2 −/− thymocytes, but the average migration speed of Git2 −/− thymocytes was significantly higher than that of wild-type thymocytes (wild-type, 3.9 μm/min; Git2 −/− , 4.8 μm/min; P = 0.03). We binned migration speeds to determine the range of greater migration speeds of Git2 −/− thymocytes (Fig. 5c) . Notably, more Git2 −/− thymocytes migrated in the velocity range of 4-6 μm/min, consistent with migration rates of DP thymocytes (3-8 μm/min) reported before 3 . To quantify directional motility, we measured the directionality index (displacement from origin divided by path length) of thymocytes migrating toward SDF-1-releasing beads by more than 20 μm (Fig. 5d) . Although the directionality index of wildtype and Git2 −/− thymocytes was not significantly different, more Git2 −/− thymocytes migrated in the speed range of 4-6 μm/min (Fig. 5d, right) . We conclude that GIT2 deficiency results in greater SDF-1-induced motility.
More Rac1 activation in Git2 −/− thymocytes The small GTPase Rac is activated in response to SDF-1 and is thought to have a critical role in cytoskeletal reorganization events that govern cell migration. Although TCR-induced activation of Rac was unchanged in Git2 −/− thymocytes relative to that in wild-type thymocytes, SDF-1-induced activation of Rac might be affected in the absence of GIT2, as we observed greater migration of Git2 −/− thymocytes in response to SDF-1. Indeed, Rac1 activation of the migration of Git2 −/− thymocytes to SDF-1 was consistently greater (Fig. 6a) , which suggested that the negative regulation of Rac1 activation by GIT2 is specific to chemokine receptor stimulation.
Treatment of wild-type thymocytes with SDF-1 transiently increased total polymerized actin (Fig. 6b) . The increase in the amount of polymerized actin was greater at all time points in Git2 −/− DP and CD4SP thymocytes. Likewise, Rac1 activation and actin polymerization transiently induced by CCL25 were greater in Git2 −/− thymocytes (data not shown). The interaction between PAK2 and the α-and β-isoforms of PIX and PAK2 kinase activity after SDF-1 stimulation were unchanged in the absence of GIT2 ( Supplementary  Fig. 5d,e) . Collectively, these data indicate that Rac1 activation and actin polymerization in response to SDF-1 or CCL25 are enhanced in the absence of GIT2. This hyperactivation probably contributes to the enhanced migratory response of Git2 −/− thymocytes. Although the effect is weak, SDF-1 also induces Erk activation in DP thymocytes. We did not find substantial differences between SDF-1-stimulated wild-type and Git2 −/− DP thymocytes in their Erk activation (Supplementary Fig. 4a , OT-II; data not shown, DO11.10). These results indicate that GIT2 negatively regulates pathways that lead specifically to Rac activation (and actin polymerization) but not those that lead to Erk activation after SDF-1 stimulation.
More migration of TCR-transgenic Git2 −/− thymocytes As with nontransgenic Git2 −/− cells, the chemotaxis of TCR-transgenic Git2 −/− DP thymocytes toward SDF-1 and CCL25 was also greater, with preselection DP thymocytes (TCR transgene low) showing a greater response than post-selection DP thymocytes (TCR transgene high; Supplementary Fig. 8a ). Under competitive conditions A r t i c l e s created by the mixture of TCR-transgenic wild-type and Git2 −/− thymocytes, TCR-transgenic Git2 −/− DP thymocytes showed more migration in response to SDF-1 and CCL25 than did GIT2-sufficient cells (Supplementary Fig. 8b ).
More Git2 −/− DP cells migrate to SDF-1 even with a TCR stop signal DP thymocytes randomly migrate in the thymus in search of a pMHC ligand for their newly formed TCR, but pMHC ligation of the TCR leads to a stop signal that prolongs the duration of thymocyte-stromal interactions from which selection 'decisions' can be made [2] [3] [4] . As loss of GIT2 resulted in more migration of DP thymocytes in response to cortical chemokines, we sough to determine whether the greater chemotactic activity of Git2 −/− thymocytes interferes with the TCRmediated stop signal. We adapted an experimental system described before 37 in which a TCR-mediated stop signal exists on the top filter of a Transwell system together with a chemokine-induced migratory signal in the bottom well. As TCR-transgenic Git2 −/− thymocytes have lower surface expression of TCRs, we used nontransgenic Git2 −/− mice, which have CD3 expression similar to that of wild-type cells. When we used control filters coated with bovine serum albumin, the migration of Git2 −/− DP thymocytes in response to SDF-1 was greater than that of wild-type cells (Fig. 7a) . When we used ICAM-1-coated filters in the presence of SDF-1, the migration of both wild-type and Git2 −/− thymocytes was much greater, which suggested that the presence of ICAM-1 facilitates Transwell migration in response to SDF-1. When we used filters coated with ICAM-1 plus antibody to CD3 (anti-CD3) in the presence of SDF-1 in the bottom well, the migration of wild-type DP thymocytes was much lower (Fig. 7b) , which suggested that the TCR-mediated stop signal is effective even though a chemotactic signal is simultaneously present. The TCR-mediated stop signal was dose dependent, as a higher concentration of anti-CD3 induced a more efficient block in migration. The effect of the TCR-mediated stop signal after SDF1-mediated migration was less potent in Git2 −/− DP thymocytes. For example, at a higher dose of anti-CD3 with ICAM-1, 25% of input Git2 −/− DP thymocytes migrated in response to SDF-1, which resulted in 2.5-fold more migration than that of wildtype DP cells. These results indicate that although the TCR-mediated stop signal can inhibit the SDF-1-mediated migration of both wildtype and Git2 −/− DP thymocytes, more Git2 −/− DP thymocytes can overcome a TCR-mediated stop signal.
Impaired scanning activity of Git2 −/− thymocytes in the cortex To determine whether GIT2 deficiency affects T cell migration in intact thymic lobes, we monitored the migration of wild-type and Git2 −/− thymocyte in the same thymic environment by two-photon laser-scanning microscopy. We mixed bone marrow cells from Git2 −/− mice expressing a transgene encoding green fluorescent protein (GFP) under control of the ubiquitin promoter and bone marrow cells from wild-type mice expressing a transgene encoding cyan fluorescent protein (CFP) under the control of the actin promoter with wild-type nonfluorescent bone marrow cells and then transferred the cells into irradiated hosts to generate partial hematopoietic chimeras in which approximately 1% of thymocytes were derived from either the GFP-expressing donor or the CFP-expressing donor. After 6-8 weeks, we monitored the migratory activity of thymocytes in explanted intact thymic lobes 30-90 μm under the thymic capsule by two-photon laser-scanning microscopy, an analysis that is limited to the cortex and cannot image the medulla or corticomedullary junction. In contrast to wild-type thymocytes, which randomly migrated in the cortex (4.74 μm/min), Git2 −/− thymocytes showed much lower motility (2.85 μm/min; Fig. 8a,b and Supplementary Movie 2). The Git2 −/− thymocytes accumulated at discrete small regions throughout the cortex, including areas near small blood vessels, and tended to circle around to their place of origin. In contrast, wild-type thymocytes tended to migrate more distally.
To quantify this activity, we calculated the directionality index of individual thymocytes. Although the directionality index tended to increase with speed for wild-type thymocytes, this was not the case for Git2 −/− thymocytes (Fig. 8c) . As a result, the directionality indices of and Git2 −/− DP thymocytes across filters coated with BSA or ICAM-1 (3 μg/ml), in response to media or SDF-1 in the bottom well; migration was quantified by flow cytometry after staining with anti-CD4 and anti-CD8 and is presented as migrating cell number/input cell number.
(b) Transwell migration of wild-type and Git2 −/− DP thymocytes across filters coated with ICAM-1 (3 μg/ml) plus either of two concentrations of anti-CD3 (5 μg/ml or 20 μg/ml), in response to media or SDF-1 in the bottom well. *0.01 < P < 0.05; **0.001 < P < 0.01; ***P < 0.001 (unpaired two-tailed Student's t-test). Data are from two independent experiments (error bars, s.e.m. of duplicate assays).
wild-type cells that migrated with average speeds between 2 μm/min and 5 μm/min were significantly greater than those of Git2 −/− thymocytes of equivalent speed (P = 0.0004 for 2-3 μm/min, P < 0.0001 for 3-4 μm/min, and P < 0.0001 for 4-5 μm/min). Furthermore, some Git2 −/− thymocytes interacted extensively with small blood vessels in the cortex, moving back and forth along their surfaces ( Fig. 8d and Supplementary Movie 3) rather than moving away from small blood vessels, as we observed the wild-type thymocytes to do (Supplementary Movie 4). One possible explanation for the altered migration of Git2 −/− thymocytes in vivo is that hypersensitivity to chemokines leads to trapping of thymocytes near local sources of chemokines in the cortex. Indeed, we confirmed here a published study reporting that SDF-1 is present at scattered sites in the cortex, including association with small blood vessels 38 (Fig. 8e) . Small blood vessels in the cortex probably deliver oxygen or nutrients, rather than serving as entry or exit portals for thymocytes, a function of postcapillary venules at the corticomedullary junction and in the adjacent medulla 39 . Furthermore, we found no evidence of more thymic entry or impaired exit, such as more T cells in blood or accumulation of CD4SP or CD8SP cells in the thymus. Together these data suggest that in the absence of GIT2, cortical thymocytes react too strongly to local chemokine gradients, which prevents them from efficiently scanning cortical epithelial cells and leads to impaired positive selection.
DISCUSSION
We have reported here that GIT2 negatively regulates the migration of DP thymocytes in response to SDF-1 and CCL25, chemokines that have critical roles in the thymus. Moreover, SDF-1-induced Rac activation and actin polymerization were substantially greater in Git2 −/− thymocytes, which suggests that GIT2 represses chemokine-induced migration by a mechanism that involves altered Rac activation and actin polymerization. Notably, the scanning activity of Git2 −/− thymocytes in intact thymic lobes was compromised because of lower motility. Because the intrinsic migratory ability of Git2 −/− thymocytes is intact and even greater than that of wild-type thymocytes in vitro, it is unlikely that in vivo migratory activity reflects the different developmental stages of Git2 −/− thymocytes. Instead, the in vivo migration defect of the Git2 −/− thymocytes is probably due to greater responses to local chemokine gradients, which cause thymocytes to be trapped near sources of chemokines in the cortex and prevents their efficient scanning of cTECs during positive selection. Hypersensitivity of Git2 −/− thymocytes to chemokine signals could result in their inability to 'reprioritize' other guidance cues presented by cTECs that facilitate TCR-pMHC interactions and instead could lead to an enhanced steady-state interaction with chemokine-expressing sources independently of TCR-pMHC interactions. Indeed, a subpopulation of Git2 −/− thymocytes interacted intensively with small blood vessels, which are often surrounded by SDF-1 + cells. The impaired scanning activity of Git2 −/− thymocytes, without detectable downstream biochemical changes in Erk activation and Ca 2+ mobilization, was accompanied by impaired positive selection in TCR-transgenic Git2 −/− mice, which suggests a causal relationship between thymocyte motility and positive selection. Unlike Git2 −/− thymocytes, which were able to sense SDF-1 and migrate toward it, Git2 −/− neutrophils have been reported to show defects in sensing the chemoattractant fMLP 27 . This difference may be due to the use of the fMLP receptor of the Gβγ-PAK1-αPIX-GIT2 signaling machinery exclusively for directional sensing. It is possible that CXCR4 in thymocytes uses different signaling machinery for sensing direction but uses GIT2 for other process, such as regulating Rac activation and actin polymerization. Our results indicate that GIT2 suppresses Rac activation after stimulation with SDF-1 or CCL25. Because Arf6 can activate Rac 21 , GIT2 may inhibit Rac activation by negatively regulating Arf6 through its GTPaseactivating activity. However, we did not detect more active Arf6 in basal or SDF-1-stimulation conditions in wild-type or Git2 −/− thymocytes by a biochemical precipitation assay (data not shown). Although this may be explained by the limited sensitivity of this assay, it is also possible that GIT2-mediated Rac suppression may be independent of the Arf GTPase-activating activity of GIT2. Further studies are needed to clarify the mechanism of GIT2-mediated repression of Rac activation.
It is unclear why preselection Git2 −/− DP thymocytes showed the most exaggerated migration responses to SDF-1 or CCL25. We considered the possibility that GIT2 protein is more abundant in the preselection DP thymocytes, but GIT2 mRNA abundance was similar in sorted CD69 lo and CD69 hi DP populations (data not shown). Another possibility is that GIT2 is a limiting factor in the preselection stage for suppression of chemotactic ability, but after positive selection, other regulators of chemotaxis are expressed, which partially compensates for the GIT2 deficiency. The identification of negative regulators of chemokine-induced migration at various developmental stages would clarify the regulation of thymocyte migration during development.
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